Wearable device with light source and optical sensor

- Rockley Photonics Limited

A wearable device with a light source and an optical sensor. In some embodiments, a system includes a wearable device for being worn by a subject and for measuring a first biomarker of a blood vessel of the subject. The wearable device may include a first light source, and a plurality of optical detectors. The system may be configured: to perform a photoplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood volume; or to perform a speckleplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood flow velocity.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATION(S)

The present application claims priority to and the benefit of U.S. Provisional Application No. 63/726,157, filed Nov. 27, 2024, entitled “WEARABLE DEVICE WITH LIGHT SOURCE AND OPTICAL SENSOR”, the entire content of which is incorporated herein by reference.

FIELD

One or more aspects of embodiments according to the present disclosure relate to biomarker monitoring, and more particularly to a system and method for measuring one or more biomarkers using one or more light sources and one or more optical sensors.

BACKGROUND

Various cardiovascular biomarkers may be clinically significant, including, for example, the blood pressure of a subject.

It is with respect to this general technical environment that aspects of the present disclosure are related.

SUMMARY

According to an embodiment of the present disclosure, there is provided a system, including: a wearable device for being worn by a subject and for measuring a first biomarker of a blood vessel of the subject, the wearable device including: a first light source, and a plurality of optical detectors, the system being configured: to perform a photoplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood volume; or to perform a speckleplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood flow velocity.

In some embodiments, the system is configured to read interleaved data from the plurality of optical detectors.

In some embodiments, the system is further configured: to read first interleaved data from a first subset of the plurality of optical detectors; and to read second interleaved data from a second subset of the plurality of optical detectors.

In some embodiments, the system is configured: to perform a first measurement, with a first optical detector of the plurality of optical detectors; to perform a second measurement, with a second optical detector of the plurality of optical detectors, the second optical detector being azimuthally separated from the first optical detector; and to determine that a measure of signal quality of the first measurement exceeds a measure of signal quality of the second measurement.

In some embodiments, the system is further configured: in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to perform a third measurement, with the first optical detector.

In some embodiments: the system is further configured: to read first interleaved data from a first subset of the plurality of optical detectors; and to read second interleaved data from a second subset of the plurality of optical detectors, wherein the first optical detector is an optical detector of the first subset, and the second optical detector is an optical detector of the second subset.

In some embodiments, the system is further configured: in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to prompt a user of the system to perform an azimuthal adjustment of the wearable device.

In some embodiments: the first biomarker is a blood flow velocity, and the plurality of optical detectors includes a first image sensor and a second image sensor azimuthally separated from the first image sensor.

In some embodiments, the first image sensor is a zero chief ray angle image sensor.

In some embodiments, an optical path between the blood vessel of the subject and the first image sensor includes no lenses.

In some embodiments, the wearable device further includes a receiving window, and the length of an optical path between the receiving window and an optical detector of the plurality of optical detectors is less than 15 mm.

In some embodiments, the wearable device further includes a receiving window, and a distance between the receiving window and an optical detector of the plurality of optical detectors is less than 5 mm.

In some embodiments: the wearable device further includes a second light source; and the system is further configured: to perform a photoplethysmography measurement with the second light source and an optical detector of the plurality of optical detectors; or to perform a speckleplethysmography measurement with the second light source and an optical detector of the plurality of optical detectors.

According to an embodiment of the present disclosure, there is provided a system, including: a wearable device for being worn by a subject and for measuring a first biomarker of a blood vessel of the subject, the wearable device including: a plurality of light sources, and a first optical detector, the system being configured: to perform a photoplethysmography measurement with each of the plurality of light sources, the first biomarker being a blood volume; or to perform a speckleplethysmography measurement with each of the plurality of light sources, the first biomarker being a blood flow velocity.

In some embodiments, the system is configured: to perform a first measurement, with a first light source of the plurality of light sources; to perform a second measurement, with a second light source of the plurality of light sources, the second light source being azimuthally separated from the first light source; and to determine that a measure of signal quality of the first measurement exceeds a measure of signal quality of the second measurement.

In some embodiments, the system is further configured: in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to perform a third measurement, with the first light source.

In some embodiments, the system is further configured: in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to prompt a user of the system to perform an azimuthal adjustment of the wearable device.

In some embodiments: the wearable device further includes a second optical detector; and the system is further configured: to perform a photoplethysmography measurement with a light source of the plurality of light sources and the second optical detector; or to perform a speckleplethysmography measurement with a light source of the plurality of light sources and the second optical detector.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other features and advantages of the present disclosure will be appreciated and understood with reference to the specification, claims, and appended drawings wherein:

FIG. 1A is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1B is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1C is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1D is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1E is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1F is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1G is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1H is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1I is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1J is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 1K is a schematic drawing of a health sensor, according to an embodiment of the present disclosure;

FIG. 2A is a schematic drawing of an images sensor and processor interface, according to an embodiment of the present disclosure;

FIG. 2B is a schematic drawing of a plurality of images sensors and processor interfaces, according to an embodiment of the present disclosure;

FIG. 2C is a schematic drawing of a plurality of images sensors and processor interfaces, according to an embodiment of the present disclosure;

FIG. 2D is a schematic drawing of a plurality of images sensors and processor interfaces, according to an embodiment of the present disclosure;

FIG. 3A is a schematic drawing of a sensor with four image sensors, over an artery, according to an embodiment of the present disclosure;

FIG. 3B is a graph of data corresponding to the configuration of FIG. 3A, according to an embodiment of the present disclosure;

FIG. 3C is a schematic drawing of a sensor with four image sensors, over an artery, according to an embodiment of the present disclosure; and

FIG. 3D is a graph of data corresponding to the configuration of FIG. 3C, according to an embodiment of the present disclosure; and

FIG. 4 is a flow chart, according to an embodiment of the present disclosure.

DETAILED DESCRIPTION

The detailed description set forth below in connection with the appended drawings is intended as a description of exemplary embodiments of a wearable device with a light source and an optical sensor provided in accordance with the present disclosure and is not intended to represent the only forms in which the present disclosure may be constructed or utilized. The description sets forth the features of the present disclosure in connection with the illustrated embodiments. It is to be understood, however, that the same or equivalent functions and structures may be accomplished by different embodiments that are also intended to be encompassed within the scope of the disclosure. As denoted elsewhere herein, like element numbers are intended to indicate like elements or features.

Referring to FIG. 1A, a health sensor (e.g., a cuffless blood pressure sensor) may include one or more light sources 110 for illuminating one or more blood vessels in a patient, or “subject”, and optical detectors 120 (e.g., a photodiode (PD) 102 or an image sensor 100 (e.g., a CMOS image sensor (CIS)) for receiving light scattered from the blood vessel (e.g., from blood inside the blood vessel). The health sensor may include (i) a photoplethysmography (PPG) sensor including a source of incoherent light 105 (e.g., S1, in FIG. 1A) and a photodetector (e.g., a single-pixel photodetector such as a photodiode 102 (PD)) for measuring the instantaneous blood volume in the blood vessel, and (ii) a speckleplethysmography (SPG) sensor (including a source of coherent light such as a laser 115 (e.g., S2, in FIG. 1A) and an image sensor 100 (e.g., a CMOS image sensor (CIS) or a charge-coupled device (CCD)) for measuring the instantaneous blood velocity in the blood vessel. Each of the instantaneous blood volume in the blood vessel, and the instantaneous blood velocity may vary with the cardiac cycle; blood pressure (both the systolic blood pressure and the diastolic blood pressure) may be inferred from a time history (or “time series”) of instantaneous blood volume measurements and a time history of instantaneous blood velocity measurements.

FIG. 1B shows the performing of a photoplethysmography measurement (with the blood vessel illuminated by the source of incoherent light, and the photodiode 102 (PD)) being used to detect the light scattering from the blood vessel into the photodiode 102. FIG. 1C shows the performing of a speckleplethysmography measurement (with the blood vessel illuminated by the source of coherent light S2, and the image sensor 100 (labeled CIS) being used to detect the light scattering from the blood vessel into the image sensor 100. When a speckleplethysmography measurement is performed, the measured speckle contrast (which is a measurement that is time-averaged over the exposure time of the image sensor 100) may decrease with increasing blood flow velocity (which may cause the speckle pattern on the image sensor 100 to change more rapidly); as such, the measured speckle contrast may be used as an indication of blood flow velocity.

Each image (or frame) generated by the image sensor 100 may be processed to calculate a data point of a time series representing a biomarker. One such biomarker may be, as mentioned above, a value that is representative of flow of blood in an artery. In such a case the alignment of the light source 110 and image sensor 100 may be such that the light scattered by the flowing blood in the artery is able to be captured by the imaging device.

For the case in which a health sensor based on laser speckle imaging (e.g., a health sensor based on speckleplethysmography) is used in a wearable device to measure the blood flow in a particular anatomical feature such as an artery, for example the radial artery at the wrist, a need to align the sensor with this anatomical feature may make the sensor performance highly dependent on device placement. The small radial artery diameter (2-3 mm) combined with the limited sensing volume offered by a sensor consisting of a single light source 110 and single image sensor 100 may contribute to this dependency on device placement.

Placing a wearable device over a non-visible blood vessel such as the radial artery on the volar side of the wrist may be challenging, especially when the body of the wearable device itself obstructs the view of skin when placed in the general area of the artery. This limits the user's ability to align the emission and detection windows of the wearable device with a location on the skin that might have been identified pre-placement via ultrasound imaging or palpitation. This last issue may be mitigated somewhat using datums on the body of the wearable device that may be positioned relative to landmarks of the subject's anatomy for alignment to the wearable device's optimal sensing point. A multi-step placement process involving first locating the blood vessel (e.g., by palpitation) relative to landmarks of the subject and then placing the wearable device at a location defined by the landmarks may be challenging for an untrained user, however. As used herein, the subject is a person wearing the wearable device, and the “user” is a person operating the wearable device. The user may be the subject or another person, e.g., a clinician.

Various aspects of the design of the wearable device may affect sensitivity to alignment. FIG. 1D shows an illumination shape in which the laser beam 125 is highly elliptical, so as to illuminate more tissue while not greatly impacting source-detector separation. Such a configuration may impact signal-to-noise ratio (SNR) performance by the addition of light not travelling through the radial artery, however. FIG. 1E shows a configuration with multiple emitters (e.g., multiple lasers 115) illuminating, with multiple respective laser beams 125, the tissue of the subject, and the artery. In such an embodiment, the lasers 115 may be turned on one at a time, to identify the laser 115 associated with the best signal-to-noise ratio performance. FIG. 1F shows an embodiment with multiple optical detectors 120. For example, three image sensors 100 may be operated in “multi-sensor” mode where frames are captured sequentially from each sensor. The effective frame rate may be divided by 3 (in the case of using 3 image sensors 100). In some such embodiments, the image sensor 100 with the best performance (which may depend on the location, relative to the light source 110 and the artery, of each of the image sensors 100) may be identified and the wearable device may then transition to using only this image sensor 100, at full frame rate. FIGS. 1G-1I show embodiments with multiple light sources 110 (e.g., multiple lasers 115 illuminating the tissue of the subject with multiple respective laser beams 125) and multiple optical detectors 120. FIGS. 1J and 1K show, respectively, an embodiment with multiple optical detectors 120 and one light source 110, and with multiple light sources 110 and one optical detector 120.

As mentioned above, to reduce the positional sensitivity of a sensor the number of transmitting elements or the number of receiving elements may be increased. In the case of a laser-based speckle imaging sensor (e.g., in the case of a speckleplethysmography sensor) this may be accomplished by increasing the number of lasers 115 or the number of image sensors 100 (or both). If multiple lasers 115 (that are not phase coherent with each other) are used, then only one laser 115 may be turned on at a time, to avoid the reduction in speckle contrast that may otherwise occur when light from several lasers 115 is received at an image sensor 100. For a convex, generally cylindrical part of the subject (such as a finger, a limb, the neck, or the torso of the subject) (which may be referred to as a “convexity” of the subject) with a blood vessel (e.g., the radial artery) extending generally parallel to, and offset from a central axis of, the part (as, for example, the radial artery at the wrist extends generally parallel to the arm and near the skin) the degree of freedom in which accurate placement may be important may be the “azimuthal” position of the sensor (which for a band securing the wearable device to the wrist may be adjusted by rotating the band (along with the wearable device) around the wrist (about the longitudinal axis of the forearm)).

Using multiple image sensors 100 offers the capability to detect over a broader physical space and cover regions where the scattered light would be generally lost when a single sensor is employed. FIG. 2A shows a simplified signal chain of the receiving elements of the wearable device. An image sensor 100 transmits image data (frames) to a processor 205 (e.g., a processing circuit) (such as a microcontroller (MCU) or field programmable gate array (FPGA)). The processor 205 receives frame data from the image sensor 100 via an interface 210 (such as a parallel bus interface or a serial interface such as the Camera Serial Interface (CSI) (promulgated by the Mobile Industry Processor Interface (MIPI) Alliance). The frames may be queued before frame processing. The queue may have a length of zero in which case frame processing occurs immediately. Frame processing extracts information from each frame received, resulting in value representative of the state of the speckle in the imaged frame captured at a time t. This value may be, for example, a measured speckle contrast. The image sensor 100 operates at a frame rate which may define the sample rate of the time series.

In some embodiments, multiple image sensors 100 are operated in parallel as illustrated in FIG. 2B. In the example shown, four image sensors 100 are shown but the design may be employed with more or fewer image sensors 100. The processor 205 in this embodiment need not be a single processor 205 but may be a distributed processor 205, including a plurality of processors 205.

In some embodiments, multiple image sensors 100 share a communication bus and an interface 210 with the processor 205, as shown in FIG. 2C. The processor 205 may have a limited number of sensor interfaces 210. An aggregator or switch or multiplexer (external to the processor 205) may be connected to the image sensors 100, and, in operation, may interleave their frame streams and transmit the resulting composite stream to the processor 205 through a single CIS interface 210. In some embodiments, a switch or multiplexer is employed to switch between generated frames, so the processor 205 receives an interleaved sequence. A switch may also be employed in a non-interleaved or non-simultaneous sampling embodiment. In such an embodiment, each image sensor 100 may be monitored for a few seconds sequentially to assess signal quality. The optimal image sensor 100 may then be identified. In this embodiment the image sensors 100 may capture frames at a simultaneous point in time at a frame rate F and transmit those frames to the processor 205 at rate NF (where N is the number of image sensors 100; e.g., N=4 in the embodiment of FIG. 2C). In some embodiments, the image sensors 100 instead capture frames sequentially, so that the rate at which each sensor runs is F/N, and the rate at which the frames are sent to the processor 205 is equal to F. In both cases the captured frames may be de-interleaved, e.g., in the processor 205 (or in a separate de-interleaving circuit) to separate into N respective streams the frames from the N image sensors 100. The processor 205 may then process the frames provided by the image sensors 100 in parallel, as illustrated in FIG. 2C.

In some embodiments, e.g., if the processor 205 lacks sufficient processing resources to process the frames in parallel, the frames are processed one at a time (e.g., in series) in the processor 205 (instead of being processed in parallel). In such an implementation, an example of which is shown in FIG. 2D, the frames in the stream provided by the image sensors 100 are processed sequentially and the corresponding data points are de-interleaved to produce a corresponding respective time series for each of the image sensors 100.

In some embodiments, the image sensors 100 are grouped into subsets, and one subset of image sensors 100 is read out at a time, in parallel or in an interleaved manner. For example, after one or more frames have been read from each of a first subset of image sensors 100, the system may switch to reading out a second subset of the image sensors 100, e.g., in an interleaved manner. Once one or more frames have been read from each of the second subset of image sensors 100, the system may switch to a third subset of the image sensors 100, and so on, or it may switch back to the first subset of the image sensors 100.

FIG. 3A shows (i) a speckleplethysmography sensor including four image sensors 100 and a single light source 110, and (ii) an artery that is the target of the speckleplethysmography sensor. The resulting representative time series from CIS 1 through 4 are shown in plot A though D respectively, of FIG. 3B; plot E of FIG. 3B shows the composite time series before de-interleaving.

FIG. 3C shows the speckleplethysmography sensor of FIG. 3A after the position of the wearable device with respect to the artery has changed (e.g., as a result of a user's moving of the wearable device). The effect on the resulting time series may be seen in the plots in FIG. 3D (in which representative time series from CIS 1 through 4 are shown in plot A though D respectively, and plot E shows the composite time series before de-interleaving); the magnitude of the time series data collected by CIS 2 and 4 is increased in comparison with the times series data corresponding to the position of FIG. 3A.

In some embodiments, a speckleplethysmography sensor utilizing multiple image sensors 100 may at startup, or periodically, be operated with all of the image sensors 100 and may then transition to a mode in which only a single image sensor 100 operates, e.g., to conserve power, or to permit the capturing and processing of images at a higher rate. The single image sensor 100 used after the transition may be the image sensor 100 generating the highest signal quality before the transition, where signal quality may be measured by a suitable algorithm (e.g. maximum peak-to-peak amplitude). FIG. 4 shows a flow chart corresponding to such a method. In the method of FIG. 4, frames are captured simultaneously from multiple image sensors 100, at 405; the frames are processed, at 410, to create time series data corresponding to each image sensor 100; the signal quality for each such time series is calculated, at 415; the image sensor 100 producing signals with the highest signal quality is identified, at 420, and the system switches, at 425, to a mode in which it uses only this identified image sensor 100. A transition back to a mode in which all of the image sensors 100 are used may be triggered by an external stimulus (e.g., an accelerometer reading exceeding a threshold) or by a real-time evaluation of the sensor time series data (e.g., peak-to-peak speckle contrast amplitude being below a threshold).

In some embodiments, a difference in signal quality between two image sensors 100 may cause the wearable device to prompt a user to perform an azimuthal adjustment of the wearable device, so as to improve the positioning of the wearable device. For example, in the situation illustrated in FIG. 3A, the system may infer, from the higher signal quality at CIS 1, that an azimuthal displacement of the wearable device, so that the position of the artery is nearer the center of the constellation of image sensors 100, may improve the signal quality at one or more of the image sensors 100, and the wearable device may prompt the user accordingly.

In some embodiments, multiple photodiodes 102, or multiple light sources 110 (e.g., multiple coherent light sources or multiple incoherent light sources) may be used in an analogous manner, to reduce the sensitivity to placement of the wearable device, or to generate information based on which a user may be prompted to adjust the azimuthal position of the wearable device.

In some embodiments with multiple image sensors 100, each image sensor 100 may receive light through a respective separate window in the wearable device (which may be shared with a respective photodiode 102), and a separate window may be used for each light source 110, or for all of the light sources 110.

An image sensor 100 designed for imaging applications may include a micro-lens array that includes one micro-lens for each pixel in the image sensor 100. Each micro-lens may concentrate the received light on the light-sensitive portion of the corresponding pixel (in some devices part of the area of the pixels is allocated to a control and readout circuit and is not light-sensitive). Such a microlens may be offset from the center of the light-sensitive portion of the corresponding pixel if the chief ray angle for the pixel, in an optical system for which the image sensor 100 is intended, is not zero, i.e., if the chief ray corresponding to the pixel is not perpendicular to the plane of the image sensor 100. This may be because the pixel is not near the center of the array (e.g., because the pixel is near the edge of the array). The offsetting of microlenses from the light-sensitive portion of the corresponding pixels may result in vignetting (lower exposure at and near the edges of the image sensor 100) in applications (such as the optodes described herein) in which the illumination is generally diffuse Lambertian illumination, which is approximately isotropic over a large solid angle, because in such a configuration a greater proportion of the received light may miss the light-sensitive portion of the corresponding pixel if the microlens is offset from the light-sensitive portion of the corresponding pixel. As such, in some embodiments, an image sensor 100 that does not include a micro-lens array, or an image sensor 100 that includes a micro-lens array and that is a zero chief ray angle (CRA) image sensor (e.g., an image sensor 100 in which each micro-lens is aligned with (not offset from) the light-sensitive portion of the corresponding pixel) may be used. As used herein, a zero chief ray angle sensor is a sensor (i) that does not include a microlens array or (ii) that includes a micro-lens array in which each chief ray angle is small (e.g., less than 5 degrees) (where the chief ray is a ray that passes through the center of the aperture and ends at the center of the light-sensitive area of the pixel, and the chief ray angle is the angle between the chief ray and a line perpendicular to the plane of the detector 120).

The distance from the sample (e.g., from the skin of the subject) to the image sensor 100 may be less than 5 mm (in a straight line) or less than 15 mm along the optical path (the latter distance being greater than the former if, for example, a folding mirror is used to cause the light from the sample to propagate parallel to the surface of the sample for some distance before reaching the image sensor 100).

The wearable device may be coupled to various other devices and systems which may perform functions of data analysis, data storage, and user interaction. For example, the wearable device may be connected (e.g., via a wireless connection) to a mobile device (such as a mobile telephone or portable (e.g., laptop) computer) and a portion of the data analysis used to convert the signals received from the optical sensors to one or more biomarkers (e.g., blood flow velocity, blood volume, or blood pressure) may be performed in the mobile device. The mobile device may also be connected to the cloud (e.g., to one or more servers connected to the Internet) and data processing and storage may be performed on the cloud. As another example, if an adjustment is to be made (e.g., an adjustment to the azimuthal position of the wearable device), the wearable device may cause the mobile device to give the user a suitable corresponding prompt.

As used herein, “a portion of” something means “at least some of” the thing, and as such may mean less than all of, or all of, the thing. As such, “a portion of” a thing includes the entire thing as a special case, i.e., the entire thing is an example of a portion of the thing. As used herein, when a second quantity is “within Y” of a first quantity X, it means that the second quantity is at least X-Y and the second quantity is at most X+Y. As used herein, when a second number is “within Y %” of a first number, it means that the second number is at least (1−Y/100) times the first number and the second number is at most (1+Y/100) times the first number. As used herein, the word “or” is inclusive, so that, for example, “A or B” means any one of (i) A, (ii) B, and (iii) A and B.

Each of the terms “processing circuit” and “means for processing” is used herein to mean any combination of hardware, firmware, and software, employed to process data or digital signals. Processing circuit hardware may include, for example, application specific integrated circuits (ASICs), general purpose or special purpose central processing units (CPUs), digital signal processors (DSPs), graphics processing units (GPUs), and programmable logic devices such as field programmable gate arrays (FPGAs). In a processing circuit, as used herein, each function is performed either by hardware configured, i.e., hard-wired, to perform that function, or by more general-purpose hardware, such as a CPU, configured to execute instructions stored in a non-transitory storage medium. A processing circuit may be fabricated on a single printed circuit board (PCB) or distributed over several interconnected PCBs. A processing circuit may contain other processing circuits; for example, a processing circuit may include two processing circuits, an FPGA and a CPU, interconnected on a PCB.

As used herein, when a method (e.g., an adjustment) or a first quantity (e.g., a first variable) is referred to as being “based on” a second quantity (e.g., a second variable) it means that the second quantity is an input to the method or influences the first quantity, e.g., the second quantity may be an input (e.g., the only input, or one of several inputs) to a function that calculates the first quantity, or the first quantity may be equal to the second quantity, or the first quantity may be the same as (e.g., stored at the same location or locations in memory as) the second quantity.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the inventive concept. As used herein, the terms “substantially,” “about,” and similar terms are used as terms of approximation and not as terms of degree, and are intended to account for the inherent deviations in measured or calculated values that would be recognized by those of ordinary skill in the art.

Any numerical range recited herein is intended to include all sub-ranges of the same numerical precision subsumed within the recited range. For example, a range of “1.0 to 10.0” or “between 1.0 and 10.0” is intended to include all subranges between (and including) the recited minimum value of 1.0 and the recited maximum value of 10.0, that is, having a minimum value equal to or greater than 1.0 and a maximum value equal to or less than 10.0, such as, for example, 2.4 to 7.6. Similarly, a range described as “within 35% of 10” is intended to include all subranges between (and including) the recited minimum value of 6.5 (i.e., (1−35/100) times 10) and the recited maximum value of 13.5 (i.e., (1+35/100) times 10), that is, having a minimum value equal to or greater than 6.5 and a maximum value equal to or less than 13.5, such as, for example, 7.4 to 10.6. Any maximum numerical limitation recited herein is intended to include all lower numerical limitations subsumed therein and any minimum numerical limitation recited in this specification is intended to include all higher numerical limitations subsumed therein.

It will be understood that when an element is referred to as being “directly connected” or “directly coupled” to another element, there are no intervening elements present. As used herein, “generally connected” means connected by an electrical path that may contain arbitrary intervening elements, including intervening elements the presence of which qualitatively changes the behavior of the circuit. As used herein, “connected” means (i) “directly connected” or (ii) connected with intervening elements, the intervening elements being ones (e.g., low-value resistors or inductors, or short sections of transmission line) that do not qualitatively affect the behavior of the circuit.

Although exemplary embodiments of a wearable device with a light source and an optical sensor have been specifically described and illustrated herein, many modifications and variations will be apparent to those skilled in the art. Accordingly, it is to be understood that a wearable device with a light source and an optical sensor constructed according to principles of this disclosure may be embodied other than as specifically described herein. The invention is also defined in the following claims, and equivalents thereof.

Claims

1. A system, comprising:

a wearable device for being worn by a subject and for measuring a first biomarker of a blood vessel of the subject,
the wearable device comprising: a first light source, and a plurality of optical detectors,
the system being configured: to perform a photoplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood volume; or to perform a speckleplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood flow velocity,
wherein the wearable device further comprises a receiving window, and the length of an optical path between the receiving window and an optical detector of the plurality of optical detectors is less than 15 mm.

2. The system of claim 1, wherein the system is configured to read interleaved data from the plurality of optical detectors.

3. The system of claim 2, wherein the system is further configured:

to read first interleaved data from a first subset of the plurality of optical detectors; and
to read second interleaved data from a second subset of the plurality of optical detectors.

4. The system of claim 1, wherein the system is configured:

to perform a first measurement, with a first optical detector of the plurality of optical detectors;
to perform a second measurement, with a second optical detector of the plurality of optical detectors, the second optical detector being azimuthally separated from the first optical detector; and
to determine that a measure of signal quality of the first measurement exceeds a measure of signal quality of the second measurement.

5. The system of claim 4, wherein the system is further configured:

in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to perform a third measurement, with the first optical detector.

6. The system of claim 5, wherein:

the system is further configured: to read first interleaved data from a first subset of the plurality of optical detectors; and to read second interleaved data from a second subset of the plurality of optical detectors,
wherein the first optical detector is an optical detector of the first subset, and the second optical detector is an optical detector of the second subset.

7. The system of claim 1, wherein:

the first biomarker is a blood flow velocity, and
the plurality of optical detectors comprises a first image sensor and a second image sensor azimuthally separated from the first image sensor.

8. The system of claim 7, wherein the first image sensor is a zero chief ray angle image sensor.

9. The system of claim 8, wherein an optical path between the blood vessel of the subject and the first image sensor includes no lenses.

10. The system of claim 1, wherein the distance between the receiving window and the optical detector is less than 5 mm.

11. The system of claim 1, wherein:

the wearable device further comprises a second light source; and
the system is further configured: to perform a photoplethysmography measurement with the second light source and an optical detector of the plurality of optical detectors; or to perform a speckleplethysmography measurement with the second light source and an optical detector of the plurality of optical detectors.

12. A system, comprising:

a wearable device for being worn by a subject and for measuring a first biomarker of a blood vessel of the subject,
the wearable device comprising: a first light source, and a plurality of optical detectors,
the system being configured: to perform a photoplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood volume; or to perform a speckleplethysmography measurement with each of the plurality of optical detectors, the first biomarker being a blood flow velocity
wherein the system is configured:
to perform a first measurement, with a first optical detector of the plurality of optical detectors;
to perform a second measurement, with a second optical detector of the plurality of optical detectors, the second optical detector being azimuthally separated from the first optical detector;
to determine that a measure of signal quality of the first measurement exceeds a measure of signal quality of the second measurement;
in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to perform a third measurement, with the first optical detector; and
in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to prompt a user of the system to perform an azimuthal adjustment of the wearable device.

13. A system, comprising:

a wearable device for being worn by a subject and for measuring a first biomarker of a blood vessel of the subject,
the wearable device comprising: a plurality of light sources, and a first optical detector,
the system being configured: to perform a photoplethysmography measurement with each of the plurality of light sources, the first biomarker being a blood volume; or to perform a speckleplethysmography measurement with each of the plurality of light sources, the first biomarker being a blood flow velocity,
wherein the system is configured: to perform a first measurement, with a first light source of the plurality of light sources; to perform a second measurement, with a second light source of the plurality of light sources, the second light source being azimuthally separated from the first light source; to determine that a measure of signal quality of the first measurement exceeds a measure of signal quality of the second measurement; in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to perform a third measurement, with the first light source; and in response to the determining that the measure of signal quality of the first measurement exceeds the measure of signal quality of the second measurement, to prompt a user of the system to perform an azimuthal adjustment of the wearable device.

14. The system of claim 13, wherein:

the wearable device further comprises a second optical detector; and
the system is further configured: to perform a photoplethysmography measurement with a light source of the plurality of light sources and the second optical detector; or to perform a speckleplethysmography measurement with a light source of the plurality of light sources and the second optical detector.
Referenced Cited
U.S. Patent Documents
4674011 June 16, 1987 Patton et al.
5243983 September 14, 1993 Tarr et al.
5497769 March 12, 1996 Gratton et al.
5532860 July 2, 1996 Hershey et al.
5772587 June 30, 1998 Gratton et al.
5830132 November 3, 1998 Robinson
6154259 November 28, 2000 Hargis et al.
6243601 June 5, 2001 Wist
6246892 June 12, 2001 Chance
6256016 July 3, 2001 Piot et al.
6560478 May 6, 2003 Alfano et al.
6919549 July 19, 2005 Bamji et al.
7035679 April 25, 2006 Addison et al.
7113817 September 26, 2006 Winchester, Jr. et al.
7202466 April 10, 2007 Babayoff et al.
7250317 July 31, 2007 Heideman
7295783 November 13, 2007 Singh et al.
7375812 May 20, 2008 Atia et al.
7474407 January 6, 2009 Gutin
7505128 March 17, 2009 Zribi et al.
7616984 November 10, 2009 Barbour et al.
7761126 July 20, 2010 Gardner et al.
7865225 January 4, 2011 Kaltschmidt et al.
7922664 April 12, 2011 Elliott
7925056 April 12, 2011 Presura et al.
8237927 August 7, 2012 Reeve et al.
8277384 October 2, 2012 Fine
8313439 November 20, 2012 McCombie et al.
8343062 January 1, 2013 Fortin et al.
8343063 January 1, 2013 Borgos
8376955 February 19, 2013 Baker, Jr.
8398556 March 19, 2013 Sethi et al.
8868149 October 21, 2014 Eisen et al.
8920332 December 30, 2014 Hong et al.
8923942 December 30, 2014 Bernreuter
8945017 February 3, 2015 Venkatraman et al.
8948832 February 3, 2015 Hong et al.
8956303 February 17, 2015 Hong et al.
8998815 April 7, 2015 Venkatraman et al.
9005129 April 14, 2015 Venkatraman et al.
9113794 August 25, 2015 Hong et al.
9113795 August 25, 2015 Hong et al.
9149216 October 6, 2015 Eisen et al.
9155480 October 13, 2015 Thakor et al.
9226673 January 5, 2016 Ferguson, Jr. et al.
9237855 January 19, 2016 Hong et al.
9307917 April 12, 2016 Hong et al.
9494567 November 15, 2016 Islam
9687162 June 27, 2017 Vetter et al.
9704050 July 11, 2017 Lee et al.
9730622 August 15, 2017 Eisen et al.
9772280 September 26, 2017 Cerussi et al.
9804027 October 31, 2017 Fish et al.
9846126 December 19, 2017 Gunn, III et al.
9848787 December 26, 2017 White et al.
9851298 December 26, 2017 Isikman et al.
9877681 January 30, 2018 Silverman
9931040 April 3, 2018 Homyk et al.
9970955 May 15, 2018 Homyk et al.
10004406 June 26, 2018 Yuen et al.
10058256 August 28, 2018 Chen et al.
10178959 January 15, 2019 Homyk et al.
10178973 January 15, 2019 Venkatraman et al.
10194808 February 5, 2019 Thompson et al.
10206576 February 19, 2019 Shcherbakov et al.
10215698 February 26, 2019 Han et al.
10241033 March 26, 2019 Uematsu et al.
10271740 April 30, 2019 Ward et al.
10314532 June 11, 2019 Ward et al.
10326035 June 18, 2019 Lu et al.
10326036 June 18, 2019 Sweeney et al.
10349847 July 16, 2019 Kwon et al.
10352768 July 16, 2019 Simpkin et al.
10357165 July 23, 2019 Yoon
10420498 September 24, 2019 Horstmeyer et al.
10422693 September 24, 2019 Fish et al.
10451537 October 22, 2019 Nakaji
10463286 November 5, 2019 Schenkman et al.
10492684 December 3, 2019 Khachaturian et al.
10506926 December 17, 2019 Khachaturian et al.
10506955 December 17, 2019 Tholl et al.
10568527 February 25, 2020 Yoon et al.
10588519 March 17, 2020 Yuen et al.
10602987 March 31, 2020 Khachaturian et al.
10627849 April 21, 2020 Scofield et al.
10641962 May 5, 2020 Nykänen et al.
10643903 May 5, 2020 Drake et al.
10667688 June 2, 2020 Khachaturian et al.
10677989 June 9, 2020 Abediasl et al.
10681259 June 9, 2020 Ichiki et al.
10681283 June 9, 2020 Nakashima et al.
10694997 June 30, 2020 Kim et al.
10718668 July 21, 2020 Gu et al.
10722177 July 28, 2020 Homyk et al.
10739256 August 11, 2020 Rickman et al.
10750956 August 25, 2020 Zalevsky et al.
10775239 September 15, 2020 Lee et al.
10813597 October 27, 2020 Rice et al.
10820858 November 3, 2020 Yoon et al.
10842422 November 24, 2020 Yu et al.
10871503 December 22, 2020 Homyk et al.
10895525 January 19, 2021 Swanson
10966616 April 6, 2021 De Morree et al.
10973422 April 13, 2021 Pantelopoulos et al.
11022751 June 1, 2021 Bauters et al.
11045103 June 29, 2021 Shchekin et al.
11079364 August 3, 2021 Leger et al.
11096601 August 24, 2021 Hong et al.
11096608 August 24, 2021 Van Dorpe et al.
11129544 September 28, 2021 Zalevsky et al.
11202582 December 21, 2021 Verkruijsse et al.
11213217 January 4, 2022 Han et al.
11278220 March 22, 2022 Tucker et al.
11298035 April 12, 2022 Huijbregts et al.
11369275 June 28, 2022 Song et al.
11445922 September 20, 2022 Naima
11553851 January 17, 2023 Kim et al.
11583185 February 21, 2023 Homyk et al.
11666238 June 6, 2023 Rege et al.
11666277 June 6, 2023 Yoon et al.
11684281 June 27, 2023 Pantelopoulos et al.
11690513 July 4, 2023 Hu et al.
11696693 July 11, 2023 Wong
11709120 July 25, 2023 Rice et al.
11744491 September 5, 2023 Dunn et al.
11751811 September 12, 2023 Sun et al.
11759116 September 19, 2023 White et al.
11759121 September 19, 2023 Mccann et al.
11771343 October 3, 2023 Sacha
11800990 October 31, 2023 White et al.
11857301 January 2, 2024 Homyk et al.
11883134 January 30, 2024 Leabman
11890081 February 6, 2024 Jang
11980451 May 14, 2024 Albert
12109006 October 8, 2024 Dunn et al.
20020195496 December 26, 2002 Tsikos et al.
20030052169 March 20, 2003 Tsikos et al.
20030137669 July 24, 2003 Rollins et al.
20050249509 November 10, 2005 Nagarajan et al.
20060124829 June 15, 2006 Song et al.
20060132790 June 22, 2006 Gutin
20060204175 September 14, 2006 Laurent-Lund et al.
20060247514 November 2, 2006 Panasyuk et al.
20070051601 March 8, 2007 Wang et al.
20070057182 March 15, 2007 Feuerbaum
20070093702 April 26, 2007 Yu et al.
20080097172 April 24, 2008 Sawada et al.
20080154126 June 26, 2008 Culver et al.
20080204752 August 28, 2008 Dorvee et al.
20080220512 September 11, 2008 Koh et al.
20080316567 December 25, 2008 Grasser et al.
20090177094 July 9, 2009 Brown et al.
20090202251 August 13, 2009 Shibayama
20090209834 August 20, 2009 Fine
20090284748 November 19, 2009 Melman et al.
20100004741 January 7, 2010 Gupta et al.
20100046234 February 25, 2010 Abu-Ageel
20100056928 March 4, 2010 Zuzak et al.
20100226646 September 9, 2010 Chan et al.
20110054277 March 3, 2011 Pinter et al.
20110082355 April 7, 2011 Eisen et al.
20110087108 April 14, 2011 Onoe et al.
20110196244 August 11, 2011 Ribas Ripoll et al.
20120130215 May 24, 2012 Fine et al.
20120232402 September 13, 2012 MacFarlane et al.
20130131475 May 23, 2013 Eisen et al.
20130190630 July 25, 2013 Borgos
20130204112 August 8, 2013 White et al.
20130278631 October 24, 2013 Border et al.
20140094666 April 3, 2014 Fine
20140118695 May 1, 2014 Shimada et al.
20140120319 May 1, 2014 Joseph
20140200423 July 17, 2014 Eisen et al.
20140313524 October 23, 2014 Banyay et al.
20140316286 October 23, 2014 Addison et al.
20140376001 December 25, 2014 Swanson
20150157224 June 11, 2015 Carmon et al.
20150196251 July 16, 2015 Outwater et al.
20150201854 July 23, 2015 Hong et al.
20150323311 November 12, 2015 Muijs et al.
20160058300 March 3, 2016 Yoon et al.
20160066790 March 10, 2016 Shcherbakov et al.
20160106327 April 21, 2016 Yoon et al.
20160157736 June 9, 2016 Huang et al.
20160161685 June 9, 2016 Xu et al.
20160183882 June 30, 2016 Henley et al.
20160195473 July 7, 2016 Fujiwara et al.
20160242647 August 25, 2016 Ishii et al.
20160266337 September 15, 2016 Feng
20160278676 September 29, 2016 Eisen et al.
20160282265 September 29, 2016 Su et al.
20160287107 October 6, 2016 Szabados et al.
20160360966 December 15, 2016 Ishii et al.
20170007138 January 12, 2017 Kim et al.
20170014037 January 19, 2017 Coppola et al.
20170065184 March 9, 2017 Barak
20170105618 April 20, 2017 Schmoll et al.
20170108439 April 20, 2017 Stievater et al.
20170138789 May 18, 2017 Ivanov
20170164878 June 15, 2017 Connor
20170188851 July 6, 2017 LeBoeuf et al.
20170231513 August 17, 2017 Presura et al.
20170315292 November 2, 2017 Mullen et al.
20180020962 January 25, 2018 Yu et al.
20180045566 February 15, 2018 Fish et al.
20180110423 April 26, 2018 Presura et al.
20180160913 June 14, 2018 Fine
20180168465 June 21, 2018 Yamada et al.
20180202927 July 19, 2018 Isikman et al.
20180228363 August 16, 2018 Frisken et al.
20180238794 August 23, 2018 Kangas et al.
20180263519 September 20, 2018 Gu
20180283950 October 4, 2018 Ge et al.
20180296168 October 18, 2018 Rice et al.
20190041736 February 7, 2019 Grunnet-Jepsen et al.
20190046056 February 14, 2019 Khachaturian et al.
20190053721 February 21, 2019 Boas et al.
20190094009 March 28, 2019 Aizawa et al.
20190094564 March 28, 2019 Rivera et al.
20190167118 June 6, 2019 Vilenskii et al.
20190175030 June 13, 2019 Verkruijsse et al.
20190336006 November 7, 2019 Horstmeyer et al.
20190343442 November 14, 2019 Aung et al.
20190343456 November 14, 2019 Kahlert et al.
20190369650 December 5, 2019 Swanson et al.
20190387972 December 26, 2019 Hu et al.
20190391243 December 26, 2019 Nicolaescu
20190391702 December 26, 2019 Jo et al.
20200003619 January 2, 2020 Hu et al.
20200011995 January 9, 2020 Send et al.
20200069225 March 5, 2020 Vizbaras et al.
20200100705 April 2, 2020 Dellimore et al.
20200143534 May 7, 2020 Wright et al.
20200158548 May 21, 2020 Rice et al.
20200196874 June 25, 2020 Rozental et al.
20200214602 July 9, 2020 Narumi et al.
20200237272 July 30, 2020 Lin et al.
20200249492 August 6, 2020 Maes
20200323440 October 15, 2020 Vule et al.
20200359948 November 19, 2020 Dunn et al.
20200397351 December 24, 2020 Miyata
20210000385 January 7, 2021 Warren et al.
20210022623 January 28, 2021 Rice et al.
20210028602 January 28, 2021 Cao et al.
20210161408 June 3, 2021 Wakita
20210186431 June 24, 2021 Jung et al.
20210267471 September 2, 2021 Bonomi et al.
20210321887 October 21, 2021 Fukazawa et al.
20210330202 October 28, 2021 Konecky
20210338083 November 4, 2021 Sie et al.
20210386310 December 16, 2021 Hong et al.
20210405518 December 30, 2021 Lablans
20220015649 January 20, 2022 Ikuta et al.
20220018762 January 20, 2022 Ekin et al.
20220019861 January 20, 2022 Durr et al.
20220039679 February 10, 2022 Califa et al.
20220061644 March 3, 2022 Fontaine et al.
20220104822 April 7, 2022 Shelton, IV et al.
20220117557 April 21, 2022 Hsu et al.
20220196557 June 23, 2022 Zheng et al.
20220211286 July 7, 2022 Tank et al.
20220265158 August 25, 2022 Tokura
20220370010 November 24, 2022 Zilkie et al.
20220413143 December 29, 2022 Parsa et al.
20230003938 January 5, 2023 Zilkie et al.
20230039055 February 9, 2023 Gardner et al.
20230048766 February 16, 2023 Frey
20230064006 March 2, 2023 Kim et al.
20230087295 March 23, 2023 Dunn et al.
20230148885 May 18, 2023 Bechtel et al.
20230148886 May 18, 2023 Bechtel et al.
20230164444 May 2023 Yang
20230225643 July 20, 2023 Scofield et al.
20230277062 September 7, 2023 Dalvi et al.
20230277075 September 7, 2023 Pantelopoulos et al.
20230296510 September 21, 2023 Xu
20230320598 October 12, 2023 Khine et al.
20230347029 November 2, 2023 Corso et al.
20230375525 November 23, 2023 Merritt et al.
20230397818 December 14, 2023 Newhouse et al.
20230401747 December 14, 2023 Dunn et al.
20240032790 February 1, 2024 Patel et al.
20240041342 February 8, 2024 Lai et al.
20240074667 March 7, 2024 Rick et al.
20240108289 April 4, 2024 Bechtel et al.
20240115212 April 11, 2024 Jang
20240156355 May 16, 2024 O'Brien et al.
20240298907 September 12, 2024 Bechtel et al.
20240350019 October 24, 2024 Pery-Shechter et al.
20240364420 October 31, 2024 Vallius et al.
20250025058 January 23, 2025 Bechtel et al.
20250169696 May 29, 2025 Dunn et al.
Foreign Patent Documents
2 861 089 January 2021 CA
108709847 October 2018 CN
110301896 October 2019 CN
211094079 July 2020 CN
211131004 July 2020 CN
112639582 April 2021 CN
114466549 May 2022 CN
3 002 568 April 2016 EP
2 395 958 December 2017 EP
3 384 841 October 2018 EP
3 558 119 November 2020 EP
3 886 686 October 2021 EP
3 903 676 November 2021 EP
WO 2024/052289 March 2014 WO
WO 2018/029123 February 2018 WO
WO 2019/149815 August 2019 WO
WO 2019/233903 December 2019 WO
WO 2020/030641 February 2020 WO
WO 2020/114989 June 2020 WO
WO 2021/058338 April 2021 WO
WO 2021/094473 May 2021 WO
WO 2021/116766 June 2021 WO
WO 2021/116766 June 2021 WO
WO 2023/031927 March 2023 WO
WO 2023/245149 December 2023 WO
WO 2024/173585 August 2024 WO
Other references
  • European Patent Office Communication pursuant to Article 94(3) EPC, for Patent Application No. 22776935.3, dated Jun. 24, 2025, 7 pages.
  • U.S. Office Action from U.S. Appl. No. 18/991,054, dated Jun. 24, 2025, 23 pages.
  • Van Gastel, M. et al., “Camera-based pulse-oximetry—validated risks and opportunities from theoretical analysis”, Biomedical Optics Express, Dec. 5, 2017, pp. 102-119, vol. 9, No. 1, Optical Society of America.
  • Website: “0.07mm Dia., TO-46 Package, InGaAs Photodiode”, 2022, printed Dec. 7, 2022, 1 page, Edmund Optics Inc., https://www.edmundoptics.com/p/ingaas-detector-70mum-dia-to-46/12571/.
  • Website: “FlowMet Peripheral Blood Flow Monitoring System”, updated Oct. 2022, printed Dec. 7, 2022, 7 pages, https://www.medtronic.com/us-en/healthcare-professionals/products/cardiovascular/intraprocedural-monitoring/flowmet.html.
  • Website: “Optical Solutions”, Molex, dated 2023, printed May 10, 2023, 13 pages, Molex, LLC, https://www.molex.com/en-us/products/optical-solutions.
  • Website: “Track Your SpO2 to Uncover Changes in Your Wellbeing”, Fitbit News, dated Sep. 7, 2020, printed Apr. 17, 2023, 7 pages, Fitbit, Inc., https://blog.fitbit.com/track-your-spo2/).626.
  • Wenz, J. J., “Examining water in model membranes by near infrared spectroscopy and multivariate analysis”, BBA—Biomembranes, Dec. 9, 2017, pp. 673-682, Elsevier B.V., https://www.sciencedirect.com/science/article/pii/S0005273617303905.
  • Xu, J. et al., “Interferometric speckle visibility spectroscopy (ISVS) for human cerebral blood flow monitoring”, APL Photonics, Dec. 4, 2020, pp. 126102-1 through 126102-10, vol. 5. AIP Publishing.
  • Xu, M. et al., “Laser Speckle Reduction Using a Motionless Despeckle Element Based on Random Mie Scattering”, Journal of Display Technology, Nov. 12, 2013, pp. 151-156, vol. 10, No. 2, IEEE.
  • Yamakoshi, Y. et al., “Side-scattered finger-photoplethysmography: experimental investigations toward practical noninvasive measurement of blood glucose”, Journal of Biomedical Optics, Jun. 2017, pp. 067001-1 through 067001-11, vol. 22, No. 6, SPIE.
  • Yao, Z. et al., “Integrated Silicon Photonic Microresonators: Emerging Technologies”, IEEE Journal of Selected Topics in Quantum Electronics, Jun. 11, 2018, 24 pages, vol. 24, No. 6, IEEE.
  • Zalevsky, Z. et al., “Novel Approaches for Near and Far Field Super Resolved Imaging”, 22nd Congress of the International Commision for Optics: Light for the Development of the World, Proc. of SPIE, Sep. 15, 2011, pp. 80116M-1 through 80116M-11, vol. 8011, No. 1, SPIE.
  • Zhang, J. et al., “III-V-on-Si photonic integrated circuits realized using micro-transfer-printing”, APL Photonics, Nov. 4, 2019, pp. 110803-1 through 110803-10.
  • Zijlstra, W. G. et al., “Absorption Spectra of Human Fetal and Adult Oxyhemoglobin, De-Oxyhemoglobin, Carboxyhemoglobin, and Methemoglobin”, Clinical Chemistry, Sep. 1991, pp. 1633-1638, vol. 37, No. 9, https://academic.oup.com/clinchem/article-abstract/37/9/1633/5649610?redirectedFrom=fulltext.
  • Zilkie, A. J. et al., “Multi-Micron Silicon Photonics Platform for Highly Manufacturable and Versitile Photonic Integrated Circuits”, IEEE Journal of Selected Topics in Quantum Electronics, Apr. 15, 2019, 13 pages, vol. 25, No. 5, IEEE.
  • Zilkie, A. J. et al., “Power-efficient III-V/Silicon external cavity DBR lasers”, Optics Express, Sep. 27, 2012, pp. 23456-23462, vol. 20, No. 21, Optical Society of America.
  • Akram, M. N. et al., “Laser speckle reduction due to spatial and angular diversity introduced by fast scanning micromirror”, Applied Optics, Jun. 4, 2010, pp. 3297-3304, vol. 49, No. 17, Optical Society of America.
  • Abookasis, D. et al., Feasibility study of hidden flow imaging based on laser speckle technique using multiperspectives contrast images, Optics and Lasers in Engineering, 2014, pp. 38-45.
  • Apsel, S. et al., “Rolling-Shutter Laser Speckle Analysis in Bio-Photonics”, Proc. of SPIE, Jun. 20, 2024, pp. 130060U-1-130060U-4, vol. 13006, SPIE.
  • Baek, H. J. et al., “The Effect of Optical Crosstalk on Accuracy of Reflectance-Type Pulse Oximeter for Mobile Healthcare”, Journal of Healthcare Engineering, Oct. 21, 2018, 9 pages, vol. 2018, Article ID 3521738, Hindawi, https://doi.org/10.1155/2018/3521738.
  • Baets, R. et al., “Spectroscopy-on-chip applications of silicon photonics”, Proc. Of SPIE, 2013, pp. 86270I-1 through 862701-10, vol. 8627, SPIE.
  • Berger, A. J. et al., “Feasibility of measuring blood glucose concentration by near-infrared Raman spectroscopy”, Spectrochimica Acta Part A, 1997, pp. 287-292, Elsevier Science B.V.
  • Bi, R. et al., “A speckle-based method for fast blood flow measurement in deep tissue”, Proceedings of SPIE, Optical Biopsy XIX: Toward Real-Time Spectroscopic Imaging and Diagnosis, Mar. 5, 2021, pp. 1163606-1 through 1163606-5, vol. 11636, SPIE.
  • Bi, R. et al., “Fast pulsatile blood flow measurement in deep tissue through a multimode detection fiber”, Journal of Biomedical Optics, May 13, 2020, pp. 055003-1 through 055003-10, vol. 25(5), SPIE.
  • Biswas, A. et al., “Fast diffuse correlation spectroscopy with a low-cost, fiber-less embedded diode laser”, Biomedical Optics Express, Oct. 4, 2021, pp. 6686-6700, vol. 12, No. 11, Optical Society of America.
  • Brouckaert, J. et al., “Silicon-on-Insulator Microspectrometer”, Proceedings Symposium IEEE/LEOS Benelux Chapter, 2008, pp. 7-10, IEEE.
  • Cole, D. B. et al., “Integrated heterodyne interferometer with on-chip modulators and detectors”, Optics Letters, Jun. 25, 2015, pp. 3097-3100, vol. 40, No. 13, Optical Society of America.
  • Epping, J. P. et al., “High power, tunable, narrow linewidth dual gain hybrid laser”, Laser Congress, Oct. 3, 2019, pp. 1-2.
  • European Patent Office Communication pursuant to Rule 114(2) EPC, for Patent Application No. 22776935.3, mailed Aug. 9, 2024, 6 pages.
  • Fu, D. et al., “In Vivo Metabolic Fingerprinting of Neutral Lipids with Hyperspectral Stimulated Raman Scattering Microscopy”, Journal of the American Chemical Society, May 28, 2014, pp. 8820-8828, American Chemical Society Publications.
  • Fukui, T. et al., “Single-Pixel Imaging Using Multimode Fiber and Silicon Photonic Phased Array”, Journal of Lightwave Technology, Jul. 14, 2020, pp. 839-844, vol. 39, No. 3, IEEE.
  • Ge, Z. et al., “Dynamic laser speckle analysis using the event sensor”, Applied Optics, Dec. 23, 2020, pp. 172-178, vol. 60, No. 1, Optical Society of America.
  • Ghijsen, M. et al., “Wearable speckle plethysmography (SPG) for characterizing microvascular flow and resistance”, Biomedical Optics Express, Jul. 30, 2018, pp. 3937-3952, vol. 9, No. 8, Optical Society of America under the terms of the OSA Open Access Publishing Agreement.
  • Goodman, J. W., “Some fundamental properties of speckle”, Journal of the Optical Society of America, Nov. 1976, pp. 1145-1150, vol. 66, No. 11, Optical Society of America.
  • Gottschling, K. et al., “Molecular Insights into Carbon Dioxide Sorption in Hydrazone-Based Covalent Organic Frameworks with Tertiary Amine Moieties”, Chemistry of Materials, Feb. 13, 2019, pp. 1946-1955, American Chemical Society.
  • Hashimoto, Y. et al., “Fabrication of an Anti-Reflective and Super-Hydrophobic Structure by Vacuum Ultraviolet Light-Assisted Bonding and Nanoscale Pattern Transfer”, Micromachines, Apr. 15, 2018, pp. 1-11, www.mdpi.com/journal/micromachines.
  • Hollis, V. S. et al., “Non-invasive monitoring of brain tissue temperature by near-infrared spectroscopy”, Proceedings of SPIE, Optical Tomography and Spectroscopy of Tissue IV, Jun. 29, 2001, pp. 470-481, vol. 4250, SPIE, https://www.spiedigitallibrary.org/conference-proceedings-of-spie/4250/1/Noninvasive-monitoring-of-brain-tissue-temperature-by-near-infrared-spectroscopy/10.1117/12.434506.short?SSO=1.
  • International Search Report and Written Opinion of the International Searching Authority, Mailed Mar. 11, 2021, Corresponding to PCT/IB2020/001037, 13 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Apr. 4, 2023, corresponding to PCT/EP2022/082341, 33 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Feb. 1, 2022, corresponding to PCT/IB2021/000649, 18 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Nov. 15, 2021, corresponding to PCT/IB2021/000517, 15 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Oct. 10, 2022, corresponding to PCT/IB2022/000373, 16 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Oct. 19, 2022, corresponding to PCT/EP2022/071467, 16 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Feb. 14, 2023, corresponding to PCT/EP2022/082162, 33 pages.
  • International Search Report and Written Opinion of the International Searching Authority, Mailed Dec. 11, 2024, Corresponding to PCT/IB2024/000388, 14 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed May 14, 2025, corresponding to PCT/IB2025/000071, 15 pages.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Jan. 2, 2023, corresponding to PCT/EP2022/074876, 13 pages.
  • Invitation to Pay Additional Fees and Partial Search Report mailed Feb. 14, 2023 in related International Application No. PCT/EP2022/082341, 18 pages.
  • Izutsu, M. et al., “Integrated Optical SSB Modulator/Frequency Shifter”, IEEE Journal of Quantum Electronics, Nov. 1981, pp. 2225-2227, vol. QE-17, No. 11, IEEE.
  • Kang, J. W. et al., “Direct observation of glucose fingerprint using in vivo Raman spectroscopy,” Science Advances, Jan. 24, 2020, pp. 1-8, American Association for the Advancement of Science.
  • Karlsson, C. J. et al., “All-fiber multifunction continuous-wave coherent laser radar at 1.55 μm for range, speed, vibration, and wind measurements”, Applied Optics, Jul. 20, 2000, pp. 3716-3726, vol. 39, No. 21, Optical Society of America.
  • Lai, M. et al., “Perfusion Monitoring By Contactless Photoplethysmography Imaging”, 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019), Venice, Italy, Apr. 8-11, 2019, pp. 1778-1782, IEEE.
  • Lai, N. et al., “CO2 Capture With Absorbents of Tertiary Amine Functionalized Nano-SiO2”, Frontiers in Chemistry, Feb. 28, 2020, pp. 1-9, vol. 8, Article 146, www.frontiersin.org.
  • Lapchuk, A. et al., “Investigation of speckle suppression beyond human eye sensitivity by using a passive multimode fiber and a multimode fiber bundle”, Applied Optics, Feb. 21, 2020, pp. 6820-6834, vol. 28, No. 5, Optical Society of America.
  • Liu, X. et al., “Simultaneous measurements of tissue blood flow and oxygenation using a wearable fiber-free optical sensor”, Journal of Biomedical Optics, Jan. 29, 2021, pp. 012705-1 through 012705-15, vol. 26, No. 1, SPIE.
  • Loi, R. et al., “Transfer Printing of AlGaInAs/InP Etched Facet Lasers to Si Substrates”, IEEE Photonics Journal, Nov. 11, 2016, 11 pages, vol. 8, No. 6, IEEE.
  • Lu, H. et al., “Single-trial estimation of the cerebral metabolic rate of oxygen with imaging photoplethysmography and laser speckle contrast imaging”, Optics Letters, Mar. 17, 2015, pp. 1193-1196, vol. 40, No. 7, Optical Society of America.
  • Mehta, D. S. et al., “Laser speckle reduction by multimode optical fiber bundle with combined temporal, spatial, and angular diversity”, Applied Optics, Apr. 11, 2012, pp. 1894-1904, vol. 51, No. 12, Optical Society of America.
  • Merritt, S. et al., “Monitoring temperature non-invasively using broadband Diffuse Optical Spectroscopy”, OSA/FIO, 2004, 1 page, Optical Society of America, https://opg.optica.org/abstract.cfm?URI=FiO-2004-FTuK4.
  • Mosso, E. et al., “Cluster speckle structures through multiple apertures forming a closed curve”, Optics Communications, 2010, pp. 1285-1290, Elsevier B.V.
  • Nabeel, P. M. et al., “Local Pulse Wave Velocity: Theory, Methods, Advancements, and Clinical Applications”, IEEE Reviews in Biomedical Engineering, Jul. 29, 2019, pp. 74-112, vol. 13, IEEE.
  • Noriki, A. et al., “45-degree curved micro-mirror for vertical optical I/O of silicon photonics chip”, Optics Express, Jul. 1, 2019, pp. 19749-19757, vol. 27, No. 14, Optical Society of America, https://doi.org/10.1364/OE.27.019749.
  • Poulton, C. V. et al., “Frequency-modulated Continuous-wave LIDAR Module in Silicon Photonics”, OFC, 2015, 4 pages, Optical Society of America.
  • Qiu, J. et al., “Correcting speckle contrast at small speckle size to enhance signal to noise ratio for laser speckle contrast imaging”, Optics Express, Nov. 15, 2013, pp. 28902-28913, vol. 21, No. 23, Optical Society of America.
  • Redding, B. et al., “Compact spectrometer based on a disordered photonic chip”, Nature Photonics, Jul. 28, 2013, pp. 746-751, vol. 7, Macmillan Publishers Limited.
  • Redding, B. et al., “Evanescently coupled multimode spiral spectrometer”, Optica, Aug. 25, 2016, pp. 956-962, vol. 3, No. 9, Optical Society of America.
  • Robinson, M. B., “Interferometric diffuse correlation spectroscopy improves measurements at long source-detector separation and low photon count rate”, Journal of Biomedical Optics, Sep. 30, 2020, pp. 097004-1 through 097004-12, vol. 25, No. 9, SPIE.
  • Roelkens, G. et al., “Transfer printing for silicon photonics transceivers and interposers”, 2018 IEEE Optical Interconnects Conference, Jun. 4, 2018, pp. 13-14, IEEE.
  • Ryckeboer, E., “Spectroscopic Detection of Glucose with a Silicon Photonic Integrated Circuit”, Universiteit Gent, Jan. 1, 2014, 263 pages, ISBN 978-90-8578-688-7, http://www.photonics.intec.ugent.be/download/phd_206.pdf.
  • Schneider, S. et al., “Optical coherence tomography system mass-producible on a silicon photonic chip”, Optics Express, Jan. 20, 2016, pp. 1573-1586, vol. 24, No. 2, Optical Society of America.
  • Sdobnov, A. Y. et al. “Speckle dynamics under ergodicity breaking”, Journal of Physics D: Applied Physics, Mar. 26, 2018, pp. 1-21, vol. 51, No. 15, IOP Publishing Ltd.
  • Shimotsu, S. et al., “Single Side-Band Modulation Performance of a LiNbO3 Integrated Modulator Consisting of Four-Phase Modulator Waveguides”, IEEE Photonics Technology Letters, Apr. 2001, pp. 364-366, vol. 13, No. 4, IEEE.
  • Subramanian, A. Z. et al., “Silicon and silicon nitride photonic circuits for spectroscopic sensing on-a-chip [Invited]”, Photon. Res., Aug. 28, 2015, pp. B47-B59, vol. 3, No. 5, Chinese Laser Press.
  • Teng, Zhongshuai et al., “In Vivo Pulse Wave Measurement Through a Multimode Fiber Diffuse Speckle Analysis System”, Frontiers in Physics, Jan. 19, 2021, pp. 1-8, vol. 8, Article 613342, www.frontiersin.org.
  • Timm, U. et al., “Non-Invasive Optical Real-time Measurement of Total Hemoglobin Content”, Procedia Engineering, 2010, pp. 488-491, Elsevier Ltd.
  • Tran, T-T-K. et al., “Speckle reduction in laser projection displays through angle and wavelength diversity”, Applied Optics, Feb. 16, 2016, pp. 1267-1274, vol. 55, No. 6, Optical Society of America.
  • Tuchin, V., “Chapter 8: Coherent Effects at the Interaction of Laser Radiation with Tissues and Cell Flows”, Tissue Optics Light Scattering Methods and Instruments for Medical Diagnostics, 3rd Edition, 2015, pp. 359-417, SPIE.
  • U.S. Advisory Action for U.S. Appl. No. 17/822,419, dated May 2, 2024, 5 pages.
  • U.S. Advisory Action for U.S. Appl. No. 17/822,419, dated Oct. 10, 2023, 6 pages.
  • U.S. Appl. No. 18/991,054, filed Dec. 20, 2024.
  • U.S. Notice of Allowance for U.S. Appl. No. 17/703,920, dated Jul. 31, 2024, 10 pages.
  • U.S. Notice of Allowance from U.S. Appl. No. 17/757,130, dated Jan. 18, 2023, 10 pages.
  • U.S. Notice of Allowance from U.S. Appl. No. 17/822,419, dated Nov. 6, 2024, 10 pages.
  • U.S. Office Action for U.S. Appl. No. 17/703,920, dated Apr. 5, 2024, 11 pages.
  • U.S. Office Action for U.S. Appl. No. 17/822,419, dated Feb. 20, 2024, 12 pages.
  • U.S. Office Action for U.S. Appl. No. 17/822,419, dated Jun. 12, 2024, 12 pages.
  • U.S. Office Action for U.S. Appl. No. 17/822,419, dated Nov. 3, 2023, 18 pages.
  • U.S. Office Action from U.S. Appl. No. 17/711,974, dated Oct. 11, 2024, 18 pages.
  • U.S. Office Action from U.S. Appl. No. 17/822,419, dated Jul. 20, 2023, 21 pages.
  • U.S. Office Action from U.S. Appl. No. 17/822,419, dated Mar. 10, 2023, 17 pages.
  • U.S. Office Action from U.S. Appl. No. 17/934,502, dated Aug. 31, 2023, 6 pages.
  • U.S. Office Action from U.S. Appl. No. 17/934,502, dated Feb. 1, 2024, 6 pages.
  • U.S. Office Action from U.S. Appl. No. 17/934,502, dated Jun. 5, 2024, 7 pages.
  • U.S. Office Action from U.S. Appl. No. 18/778,893, dated Apr. 22, 2025, 9 pages.
  • U.S. Office Action from U.S. Appl. No. 18/991,054, dated Mar. 3, 2025, 19 pages.
  • Valley, G.C. et al., “Multimode waveguide speckle patterns for compressive sensing”, Optics Letters, May 23, 2016, pp. 2529-2532, vol. 41, No. 11, Optical Society of America.
  • International Search Report and Written Opinion of the International Searching Authority, mailed Jun. 23, 2025, corresponding to PCT/IB2025/000070, 15 pages.
Patent History
Patent number: 12396648
Type: Grant
Filed: Dec 17, 2024
Date of Patent: Aug 26, 2025
Assignee: Rockley Photonics Limited (Altrincham)
Inventor: James McMillan (Santa Monica, CA)
Primary Examiner: Deborah L Malamud
Application Number: 18/984,845
Classifications
International Classification: A61B 5/02 (20060101); A61B 5/021 (20060101); A61B 5/026 (20060101); A61B 5/0295 (20060101);